Investors

Insider Transactions

Date Name Title Type Shares Traded Sorted Descending Price Range
May 6, 2013 aberman michael s Officer Sell 8,334 256.46 - 257.29
May 6, 2013 aberman michael s Officer Option Execute 8,334 24.00
May 8, 2013 terifay robert j Officer Sell 8,231 260.86 - 262.06
Nov 13, 2012 goldberg murray a Officer Option Execute 8,176 8.50 - 65.76
Aug 28, 2008 roberts william Officer Acquisition (Non Open Market) 8,106 n/a
Aug 28, 2008 vagelos p roy Director Disposition (Non Open Market) 8,106 n/a
Jul 9, 2008 vagelos p roy Director Disposition (Non Open Market) 8,105 n/a
Jul 15, 2010 roberts william Officer Acquisition (Non Open Market) 8,041 n/a
Oct 4, 2010 vagelos p roy Director Disposition (Non Open Market) 8,035 n/a
Dec 21, 2009 gilman alfred g Director Disposition (Non Open Market) 8,000 n/a
Jul 25, 2012 powchik peter Officer Automatic Sell 7,981 126.76
Apr 12, 2010 vagelos p roy Director Disposition (Non Open Market) 7,952 n/a
Sep 6, 2011 schleifer leonard s Officer Automatic Sell 7,900 63.01 - 68.42
Jan 16, 2013 goldberg murray a Officer Automatic Sell 7,878 170.57 - 174.56
Sep 18, 2012 powchik peter Officer Automatic Sell 7,823 148.78
Mar 30, 2011 stahl neil Officer Automatic Sell 7,692 45.00
Mar 30, 2011 stahl neil Officer Option Execute 7,692 13.00
Sep 9, 2011 goldberg murray a Officer Automatic Sell 7,542 67.19 - 69.08
Dec 10, 2012 aberman michael s Officer Option Execute 7,500 30.63
Nov 23, 2010 shooter eric m Director Automatic Sell 7,500 30.00
Showing 361-380 of 627 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)